AbbVie Inc's Fiscal Year is From January To December.
The item "Price-Earnings-Ratio" stands at 158.00 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of AbbVie Inc's third quarter, the item "Price Earnings Ratio" stands at 158.00. This represents an increase of 90.74 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 148.08 percent compared to the value the year prior.
The 1 year change in percent is 148.08.
The 3 year change in percent is 788.48.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price Earnings Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price Earnings Ratio | 486,508,953,600.00 |
![]() | Roche Holding AG - Price Earnings Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price Earnings Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Price Earnings Ratio | 255,096,620,580.91 |